Eucrates Biomedical Acquisition Cor... (EUCR)
$10.04
0.00 (0.00%)
Rating:
Recommendation:
-
Symbol | EUCR |
---|---|
Price | $10.04 |
Beta | -0.074 |
Volume Avg. | 0.00M |
Market Cap | 42.229M |
Shares () | - |
52 Week Range | 9.87-10.25 |
1y Target Est | - |
DCF Unlevered | EUCR DCF -> | |
---|---|---|
DCF Levered | EUCR LDCF -> | |
ROE | 6.98% | Neutral |
ROA | 43.59% | Strong Buy |
Operating Margin | - | |
Debt / Equity | 0.70% | Neutral |
P/E | 47.81 | Strong Buy |
P/B | 10.20 | Strong Buy |
About
Download (Excel)Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.